Sponsored By:

10 Big Pharma Stocks to Buy

Maintain your quality of life by smartly stocking your portfolio

    View All  

Jazz Pharmaceuticals (NASDAQ:JAZZ) is a biopharmaceutical company involved with the identification, development and commercialization of pharmaceutical products. Year-to-date, JAZZ stock has jumped nearly 125%, compared to small losses by the broader markets.

Johnson & Johnson (NYSE:JNJ) is perhaps the most famous stock on this list, for its wide-ranging portfolio of health care products. JNJ may not be the biggest winner on the list, but its modest return of 3% has shareholders pleased.

Perrigo Co. (NASDAQ:PRGO) is an international company that develops, manufactures and distributes over-the-counter products and medicines. Despite a volatile market, PRGO has given its shareholders a steady return of 55%, year-to-date.

Questcor Pharmaceuticals (NASDAQ:QCOR) is a biopharmaceutical company best known for its hallmark product H.P. Acthar Gel, which is an injectable drug used to remedy 19 conditions. QCOR is the biggest gainer on this list, up 121%, year-to-date.

Shire (NASDAQ:SHPGY) focuses on the needs of specialty physicians and develops products for a wide range of disorders and diseases.  While the Dow Jones has dropped 1% in 2011, SHPGY has jumped an impressive 30%.

Watson Pharmaceuticals (NYSE:WPI) is another global pharmaceutical company that develops generic products and medicines. The generics developer WPI has gained 30%, year-to-date.

Get more analysis of these picks and other publicly-traded stocks with Louis Navellier’s Portfolio Grader tool, a 100% free stock-rating tool that measures both quantitative buying pressure and eight fundamental factors.


Article printed from InvestorPlace Media, http://investorplace.com/2011/10/10-big-pharma-stocks-to-buy-akrx-agn-bmy-eln-jazz-jnj-prgo-qcor-shpgy-wpi/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.